HRI received $100,000 from the Canadian Centre on Substance Use and Addiction (CCSA) and Health Canada to study the effects of cannabis legalization on at-risk populations.HRI’s Director of Evaluation, Dr. Jean Costello, led the study, which utilized patient data from Homewood Health Centre and St. Joseph’s Healthcare Hamilton. The study was co-led by HRI Senior […]
Read MoreKey findings released from study exploring impacts of cannabis legalization
Last year, HRI received $100,000 in funding from the Canadian Centre on Substance Use and Addiction (CCSA) and Health Canada to study the effects of cannabis legalization on at-risk populations. Findings from this project are now available.
Read MoreHRI-CCSA partnership accelerates progress in addiction research and evaluation
HRI is proud to partner with the Canadian Centre on Substance Use and Addiction (CCSA). Together, we’re closing knowledge gaps and advancing knowledge about substance use and addiction in Canada.
Read MoreHRI welcomes Post-Doctoral Fellow improving individualized care for addiction-related illness
We are proud to welcome Marie Gendy, MD, MSc and PhD, to HRI as a Post-Doctoral Fellow. Dr. Gendy joins us through the Mitacs Accelerate Industrial Fellowship program. Her work explores diverse characteristics among people with addiction-related illness to help identify targeted treatment approaches that better match individual needs.
Read MoreDarlene Walton Scholarship Award winner
Congratulations to Emily Levitt, who is this year’s recipient of the Darlene Walton Scholarship Award! This award recognizes students who demonstrate excellence in mental health and addiction research, doing work that enhances practice.
Read MoreInfographic: new findings from study exploring long-term recovery from addiction
HRI has released a new infographic featuring recent findings from a study shedding light on the process of recovery from mental illness and addiction.
Read MoreHRI awarded $100K from CCSA, Health Canada to explore impacts of cannabis legalization
HRI is the proud recipient of $100,000 in funding from the Canadian Centre on Substance Use and Addiction (CCSA) and Health Canada to study the effects of cannabis legalization on at-risk populations, including people requiring treatment for mental illness and substance use disorder (SUD).
Read MoreNew findings focus on screening tools that can improve addiction treatment and planning
In our latest Research Snapshot, we profile findings about improvements to screening tools that may help to identify concurrent mental health conditions in people requiring treatment for addiction.
Read MoreNew funding will support research exploring impact of COVID-19 on mental health
HRI Senior Scientist, Dr. James MacKillop, has received $491,000 from the Canadian Institutes of Health Research (CIHR) for a study that will examine the impact of COVID-19 on mental health and substance use.
Read MoreInternational study explores how AA contributes to recovery
Treatment of alcohol use disorder is multi-faceted and often includes participation in mutual-support groups, the oldest and largest of which is Alcoholics Anonymous (AA). Although frequent AA meeting attendance is associated with greater abstinence from alcohol, there is little understanding of the specific mechanisms by which AA benefits people. In other words, we know that AA works, […]
Read More